Substituted biaryl compounds for inflammation and...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 263/32 (2006.01) A61K 31/4164 (2006.01) A61P 37/06 (2006.01) C07C 211/52 (2006.01) C07C 229/52 (2006.01) C07C 233/53 (2006.01) C07C 233/63 (2006.01) C07D 207/16 (2006.01) C07D 211/62 (2006.01) C07D 213/60 (2006.01) C07D 277/28 (2006.01) C07D 317/58 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01)

Patent

CA 2639927

The invention relates to compounds of structural formula (I): Formula (I) or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein A, Y, L, R1, W1 and W2 are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

L'invention concerne des composés de formule développée (I) ou un sel, solvate, clathrate ou promédicament acceptable sur le plan pharmaceutique de ceux-ci, dans laquelle Y, L, A, W1, W2 et R'1 sont définis dans la description. Ces composés sont utiles comment agents immunosuppresseurs et pour le traitement et la prévention d'états inflammatoires, de troubles allergiques et de troubles immunitaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted biaryl compounds for inflammation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted biaryl compounds for inflammation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted biaryl compounds for inflammation and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1735401

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.